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The human pathogen Yersinia pestis requires the assembly of the type III
secretion system (T3SS) for virulence. The structural component of the T3SS
contains an external needle and a tip complex, which is formed by LcrV
in Y. pestis. The structure of an LcrV triple mutant (K40A/D41A/K42A) in a
C273S background has previously been reported to 2.2 Å resolution. Here, the
crystal structure of LcrV without the triple mutation in a C273S background is
reported at a higher resolution of 1.65 Å. Overall the two structures are similar,
but there are also notable differences, particularly near the site of the triple
mutation. The refined structure revealed a slight shift in the backbone positions
of residues Gly28–Asn43 and displayed electron density in the loop region
consisting of residues Ile46–Val63, which was disordered in the original
structure. In addition, the helical turn region spanning residues Tyr77–Gln95
adopts a different orientation.
1. Introduction
The Gram-negative bacterium Yersinia pestis, which is the causative
agent of bubonic plague, has caused pandemics that have resulted in
large-scale social devastation. The type III secretion system (T3SS)
plays a critical role in the pathogenicity of Y. pestis as well as that of
other human pathogens such as Shigella flexneri, Salmonella typhi-
murium and Burkholderia pseudomallei (Cornelis, 2006). The T3SS
is a complex nanomachine that is utilized by pathogenic bacteria to
deliver bacterial effector proteins into the cytosol of targeted host
cells (Cornelis, 2002, 2006). The structural component of the T3SS
is a needle apparatus which is assembled from over a dozen different
proteins and is composed of a basal-membrane-embedded structure,
an external needle, a tip complex and a translocon. The external
needle of the Y. pestis T3SS (also known as the Ysc–Yop system) is
formed by polymerization of YscF and ends in a tip complex formed
by multiple copies of LcrV which serves as a platform for the
assembly of the translocon proteins YopB and YopD (Cornelis, 2002).
Prior to assembly at the needle tip, LcrV is chaperoned by a smaller
protein, LcrG (DeBord et al., 2001; Matson & Nilles, 2001).
The 2.2 Å resolution crystal structure of LcrV (residues Leu24–
Lys326) was reported in 2004 using a construct containing triple
mutations (K40A/D41A/K42A) in a C273S background (Derewenda
et al., 2004). Since then, crystal structures of other T3SS tip proteins
such as the Shigella IpaD (Johnson et al., 2007), the Salmonella SipD
(Chatterjee et al., 2011; Lunelli et al., 2011) and the Burkholderia
BipD (Erskine et al., 2006; Johnson et al., 2007) tip proteins have been
determined. The T3SS tip proteins share common structural motifs as
well as variations among bacterial species. Here, the refined structure
of LcrV is reported at 1.65 Å resolution, which highlights structural
similarities as well as differences that exist between two constructs of
the same protein.
2. Methods
2.1. Protein expression and purification
The DNA region coding for Y. pestis LcrV residues Gly28–Asp322
with a C273S point mutation was subcloned as a fusion protein with a
His6-tagged streptococcal GB1 domain and a tobacco etch virus
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(TEV) protease site. The subcloning introduced a three-residue
(GHM) cloning artifact at the N-terminus of LcrV following cleavage
of the fusion tag. The expression plasmid was transformed into
Escherichia coli BL21(DE3) DNAY and a 10 ml overnight starter
culture was used to inoculate a 1 l LB culture. The cells were grown at
310 K to an OD600 of 0.6–0.8 and were induced with 1 mM IPTG
overnight at 288 K. The cells were harvested, resuspended in 30 ml
binding buffer (500 mM NaCl, 20 mM Tris–HCl, 5 mM imidazole pH
8.0) and stored at 253 K. To purify LcrV, the frozen cells were
warmed to 277 K, lysed by sonication and centrifuged to remove the
cellular debris. The supernatant was loaded onto a 5 ml nickel-affinity
column (Sigma) and washed with the binding buffer. The protein was
eluted using 500 mM NaCl, 20 mM Tris–HCl, 250 mM imidazole pH
8.0. Fractions containing LcrV were combined and dialyzed overnight
against 1 l TEV digestion buffer (50 mM Tris, 0.5 mM EDTA, 1 mM
DTT, 20 mM NaCl pH 8.0) in the presence of 300 ml 0.06 mM
recombinant TEV protease (Geisbrecht et al., 2006). The mixture was
passed over a nickel-affinity column to separate LcrV from the GB1
fusion partner and TEV protease. Fractions containing LcrV were
pooled, dialyzed against 50 mM NaCl, 20 mM Tris pH 8.0 and
concentrated to 22 mg ml1 (0.6 mM) using an Amicon Ultra 3K
concentrator (Millipore).
2.2. Crystallization and data collection
Crystallization screening was conducted at 293 K in Compact
Clover (Emerald BioSystems) sitting-drop vapor-diffusion plates
using 0.5 ml protein solution and 0.5 ml crystallization solution equi-
librated against 75 ml crystallization solution. Initial crystals, which
formed plate clusters, were obtained in approximately 24 h from
Index HT screen (Hampton Research) conditions D8 (25% PEG
3350, 100 mM HEPES pH 7.5) and D9 (25% PEG 3350, 100 mM Tris
pH 8.5). The crystallization conditions were refined using the pH
Buffer Screen (Emerald BioSystems) and the prismatic crystals used
for data collection were obtained using 25% PEG 3350, 100 mM
Bicine pH 7.0 (Fig. 1). Single crystals were transferred to a fresh drop
of a cryoprotectant solution consisting of 80% crystallization solution
and 20% PEG 400. X-ray diffraction data were obtained using a
PILATUS 6M pixel-array detector (Dectris) on beamline 17ID
(IMCA-CAT) at the Advanced Photon Source.
2.3. Structure solution and refinement
The diffraction data were integrated and scaled using XDS
(Kabsch, 1988) and SCALA (Evans, 2006), respectively. The Laue
class was checked with POINTLESS (Evans, 2006), which indicated
that 2/m was correct and that the likely space group was P21. Struc-
ture solution was conducted with Phaser (McCoy et al., 2007) via the
PHENIX (Adams et al., 2010) interface using a previously deter-
mined structure of LcrV (PDB entry 1r6f; Derewenda et al., 2004) as
the search model. Searches were conducted in space groups P2 and
P21, with the top solution being obtained in the latter. Following
manual model building with Coot (Emsley & Cowtan, 2004), the
structure was improved by automated model building with ARP/
wARP (Langer et al., 2008). Structure refinement and additional
model building were performed with PHENIX and Coot, respec-
tively. Disordered side-chain residues were truncated at the point to
which electron density could be observed. Structure validation was
conducted with MolProbity (Chen et al., 2010). Crystallographic data
are provided in Table 1.
3. Results and discussion
The final model contained residues Gly28–Leu319, a PEG 400
molecule and 149 water molecules (Fig. 2). Residues Lys261–Pro279
structural communications
478 Chaudhury et al.  LcrV Acta Cryst. (2013). F69, 477–481
Figure 1
Prismatic crystals of LcrV (Gly28–Asp322, C273S). Initial crystals were observed
from Index HT screen conditions D8 and D9. Refined crystals were obtained using
the pH Buffer Screen.
Table 1
Crystallographic data for LcrV (Gly28–Asp322, C273S) refined to 1.65 Å
resolution.
Values in parentheses are for the highest resolution shell.
Data collection
Unit-cell parameters (Å, ) a = 39.51, b = 51.44, c = 65.18,
 = 92.00
Space group P21





Mean I/(I) 18.0 (2.2)
Completeness (%) 99.3 (99.8)
Multiplicity 3.3 (3.3)
Rmerge† (%) 3.4 (50.5)
Rmeas‡ (%) 4.0 (60.3)











Bond lengths (Å) 0.011
Bond angles () 1.196





Coordinate error based on maximum likelihood (Å) 0.24
Ramachandran plot
Most favored (%) 98.9









i IiðhklÞ, where Ii(hkl) is the intensity
measured for the ith reflection and hI(hkl)i is the average intensity of all reflections
with indices hkl. ‡ Rmeas is the redundancy-independent (multiplicity-weighted) Rmerge
(Evans, 2006). § Rp.i.m. is the precision-indicating (multiplicity-weighted) Rmerge









Rfree is calculated in an identical manner using a randomly selected 5% of the reflections,
which were not included in the refinement
could not be fitted to the electron density owing to disorder. The
overall structure of LcrV is similar to that reported previously (PDB
entry 1r6f; Derewenda et al., 2004), with an r.m.s.d. between C atoms
(244 residues) of 1.62 Å as determined using secondary-structure
matching (Krissinel & Henrick, 2004) in Coot (Emsley et al., 2010).
Similar to 1r6f (Derewenda et al., 2004), LcrV is mainly an -helical
protein, with 55% of the residues present in 12 -helices (1–12),
7% of the residues present in six -strands and 32% of the residues
present in random coils. The overall shape of the protein structure
can be described as ‘dumbbell-shaped’ and is composed of a central
coiled-coil region connecting two globular domains (Derewenda et
al., 2004). The N-terminal globular domain (residues Gly25–Gly147)
is formed by two antiparallel -strands (1 and 2) and six helices
(1–6) and packs at one end of a long central coiled coil formed by
helix 7 and helix 12. The central coiled coil connects to a second
globular domain formed by a mixture of -helices and -strands. This
mixed / domain is less structured compared with the N-terminal
globular domain and contains four short helices (8–11) and four
antiparallel -strands (3–6). The bulk of the / domain is
unstructured and is composed of coils and turns connecting the short
helices and the -strands.
However, there are significant differences between 1r6f and the
current structure. In the N-terminal domain, differences exist at
residues Gly28–Asn43, Ile46–Val63 and Tyr77–Gln95 (Fig. 3). Resi-
dues Gly23–His27 could not be modeled in PDB entry 1r6f; however,
in the current structure residues Gly28–Ser30 formed a random coil,
with helix 1 starting at Val31 (helix 1 starts at Gly28 in 1r6f). The
relative orientation of helix 1 is also slightly shifted compared with
the equivalent helix in 1r6f. In 1r6f, residues Lys49–Val63 were not
visible in the electron-density map owing to disorder (Derewenda
et al., 2004), whereas in the current structure Ile46–Val63 form an
ordered loop that packs at the C-terminal end of one of the helices
(helix 12) of the central coiled coil. Additionally, the helical turn
spanning residues Tyr77–Gln95 adopts different orientations in the
two structures and Tyr90, which was not visible in 1r6f, could be
modeled in the current structure. In 1r6f the residues Asn260–Asp275
could not be modeled. Similarly, in our model the residues Lys261–
Pro279 could not be modeled owing to disorder.
As noted above, the 1r6f structure was solved using the triple
mutant K40A/D41A/K42A in a C273S background, whereas the
LcrV structure reported here only has the background C273S
mutation. The C273S point mutation facilitated protein purification
and the triple mutation (K40A/D41A/K42A) at the terminal end of
helix 1 facilitated crystallization (Derewenda et al., 2004). Most of
the significant differences between the 1r6f structure and the current
structure are in the helix containing the triple mutation and in the
region spanning Tyr77–Gln95. The differences in these regions of the
two structures may be a consequence of crystal packing. It should be
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Figure 2
Crystal structure of LcrV refined to 1.65 Å resolution. LcrV can be divided into
three domains: the N-terminal globular domain (pale pink), the central coiled-coil
domain (green) and the less structured mixed / domain (light blue).
Figure 3
The differences in the N-terminal domain of the refined stucture of LcrV from that
of PDB entry 1r6f.
Figure 4
Superposition of the refined structure of LcrV with that of PDB entry 1r6f. (a) A loop spanning Lys49–Arg62 from a symmetry-related molecule (gray) in the current
structure would clash with the Tyr77–Gln95 region (blue) of PDB entry 1r6f. (b) Conformational changes in the Gly25–Asn43 region are shown by the curved arrow and
those in the Tyr77–Gln95 region are indicated by straight arrows. (c) Hydrogen-bond crystal contacts (dashed lines) observed in the current structure. Symmetry-related
molecules are colored gray. The Lys40–Lys42 region from 1r6f is indicated.
noted that the ‘tightness’ of the crystal packing, as gauged from
the solvent content (39.1% for 1r6f versus 37.0% for the current
structure) and the Matthews coefficient (2.02 Å3 Da1 for 1r6f versus
1.95 Å3 Da1 for the current structure), is similar in the two struc-
tures. However, the Tyr77–Gln95 region appears to be precluded
from adopting a conformation similar to that observed for 1r6f owing
to a nearby loop from a symmetry-related molecule (Fig. 4a). Thus,
Tyr77–Gln95, which is random coil in 1r6f, is composed of a helix and
a sheet (3 and 2) in the current structure. This in turn appears to
result in movement of the N-terminus from Gly25 to Val31 to form
the 1 strand, which adopts an antiparallel orientation to 2, and a
slight shift in helix 1 relative to 1r6f (Fig. 4b). It was noted that the
site of the triple mutant in 1r6f forms a crystal contact with Lys176
(Derewenda et al., 2004), although it does not appear to form a direct
hydrogen bond but is rather in proximity to the mutation sites. In the
current structure, new hydrogen bonds between symmetry-related
molecules are formed at the ends of helix 1, as shown in Fig. 4(c).
The triple mutations in 1r6f are located in the N-terminal domain of
LcrV, which forms the base of the tip complex and is suggested to be
involved in protein–protein interaction with the translocon (Broz et
al., 2007). Thus, the refined crystal structure of LcrV reported here
with native residues in the N-terminal domain will be useful in future
structural studies of the LcrV–translocon interaction.
There is low sequence identity between LcrV and the tip proteins
IpaD (Johnson et al., 2007), BipD (Erskine et al., 2006; Johnson et al.,
2007) and SipD (Chatterjee et al., 2011; Lunelli et al., 2011). LcrV is
more closely related to PcrV, the tip protein of Pseudomonas aeru-
ginosa (Derewenda et al., 2004), for which a crystal structure is not
available. Nevertheless, despite poor sequence similarity to IpaD,
BipD and SipD, the LcrV central coiled coil (forming the handle of
the dumbbell) is conserved and forms a common structural feature
among T3SS tip proteins (Fig. 5; Erskine et al., 2006; Johnson et al.,
2007; Lunelli et al., 2011; Chatterjee et al., 2011). The structural
conservation of the central coiled coil among T3SS tip proteins
suggests an important role in T3SS function. Others have hypothe-
sized that the central coiled coil plays an important role in the
assembly of the T3SS tip complex (Deane et al., 2006; Blocker et al.,
2008). Recently, it has been shown that the central coiled coil of SipD
is the site of protein–protein interactions with the needle protein and
is important in the assembly of the T3SS needle apparatus (Rathi-
navelan et al., 2011; Lunelli et al., 2011).
With respect to structural differences among T3SS tip proteins, the
LcrV N-terminal globular domain is unique to LcrV and is absent in
IpaD (Johnson et al., 2007), BipD (Erskine et al., 2006; Johnson et al.,
2007) and SipD (Chatterjee et al., 2011; Lunelli et al., 2011) (Fig. 5).
In IpaD, BipD and SipD the N-terminal region forms an -helical
hairpin that has been proposed to be a self-chaperone for these tip
proteins (Johnson et al., 2007; Erskine et al., 2006; Blocker et al.,
2008). However, in LcrV a small 95-residue protein, LcrG, functions
as a chaperone via the formation of a protein complex (Matson &
Nilles, 2001, 2002; Lawton et al., 2002; Blocker et al., 2008). Another
difference between LcrV and the self-chaperoned tip proteins (IpaD,
BipD and SipD) is that the C-terminal helix of the central coiled coil
(helix 12) is bent and kinked, whereas in the other tip proteins
the equivalent helix is straight (Fig. 5; Blocker et al., 2008). These
structural differences suggest that the needle-tip assembly process
may vary between T3SS family members.
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